CorMedix (CRMD) Total Liabilities (2010 - 2025)

CorMedix (CRMD) has 15 years of Total Liabilities data on file, last reported at $420.8 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 1130.91% year-over-year to $420.8 million; the trailing twelve-month figure through Dec 2025 stood at $420.8 million (up 1130.91% YoY), and the FY2025 full-year result was $420.8 million, up 1130.91% from the prior year.
• Total Liabilities advanced to $420.8 million in Q4 2025, from $376.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $420.8 million in Q4 2025 to a low of $3.9 million in Q1 2021.
• A 5-year average of $50.8 million and a median of $8.1 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities slumped 32.08% in 2021 and jumped 1896.05% in 2025, its largest moves.
• Tracing CRMD's Total Liabilities over 5 years: stood at $6.1 million in 2021, then advanced by 13.52% to $7.0 million in 2022, then soared by 70.77% to $11.9 million in 2023, then soared by 186.88% to $34.2 million in 2024, then surged by 1130.91% to $420.8 million in 2025.
• Business Quant data shows CRMD's Total Liabilities at $420.8 million in Q4 2025, $376.7 million in Q3 2025, and $32.0 million in Q2 2025.